Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup
Yusuke Hara(Kitasato University), Yasuhide Hayashi(Gunma Children's Medical Center), Manabu Sotomatsu(Gunma Children's Medical Center), Daisuke Tomizawa(National Center For Child Health and Development), Takashi Taga(Erasmus MC), Norio Shiba(Gunma University), Akio Tawa(Erasmus MC), Kentaro Ohki(National Center For Child Health and Development), Akitoshi Kinoshita(St. Marianna University School of Medicine), Genki Yamato(Gunma University), Souichi Adachi(Kyoto University), Nobutaka Kiyokawa(National Center For Child Health and Development), Hirokazu Arakawa(Institute of Molecular and Cell Biology), Ken Tabuchi, Tomohiko Taki(Kyorin University), Akiko Saito(Nagoya University Hospital), Keizo Horibe(National Hospital Organization)
Cited by 31
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
International consensus on (ICON) pediatric asthma
|Allergy|2012|462
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383